Here, we show a tumor-promoting stabilization mechanism of KRAS via another oncogenic protein, DX2, and propose the interface of the two oncogenic factors as an alternative and effective route to control KRAS-driven cancers. This evidence concerns the gene KRAS and neoplasm.